Programs Department, Nigeria Solidarity Support Fund, Lagos, Nigeria.
Management, Nigeria Solidarity Support Fund, Lagos, Nigeria.
Front Public Health. 2023 Sep 21;11:1199481. doi: 10.3389/fpubh.2023.1199481. eCollection 2023.
The first set of vaccines arrived in Nigeria in March 2021. The National Primary Health Care Development Agency (NPHCDA) set out to vaccinate at least 70% percent of Nigeria's eligible population, i.e., 111,776,503 people, by December 2022. As of June 2021, only 3% had received at least one dose of the vaccine. This presented a threat to the achievement of NPHCDA's goal. Nigeria Solidarity Support Fund (NSSF) went into a partnership with NPHCDA to accelerate the uptake of COVID-19 vaccinations across Nigeria over 3 months.
Across Nigeria's 6 geopolitical zones, 6 states were selected, namely: Adamawa, Edo, Imo, Katsina, Nasarawa, and Ogun states based on performance, political will, and absence of external resources. A two-pronged approach was implemented: unrestricted funding to the sub-national level and providing technical support at the national level.
5 out of 6 states received unrestricted funding to ramp up vaccination coverage. They also received adequate vaccine supplies. A total of 12,000 healthcare workers were trained on safe immunization practices and multiple communities were engaged across the 133 local government areas (LGAs) through religious and community leaders. After 6 months, there was an average of 35% increase in the uptake of COVID-19 vaccines in the 5 states. An indicator tracker was developed for weekly reviews at the national level and the total population vaccinated in Nigeria increased from 6,186,647 to 11,985,336 at the end of the partnership.
Unrestricted funding, though not without its risks, can yield a significant impact on health. The intervention was co-designed with stakeholders and had leadership buy-in, accountability mechanisms, with unrestricted funding. These techniques produced an increase in the vaccination rates in the 5 states and across the country. These elements should be explored for application to other program designs such as routine immunization.
尼日利亚于 2021 年 3 月收到第一批疫苗。国家初级卫生保健发展署（NPHCDA）设定目标，到 2022 年 12 月，为至少 111776503 名符合条件的尼日利亚人接种疫苗，接种率至少达到 70%。截至 2021 年 6 月，只有 3%的人至少接种了一剂疫苗。这对 NPHCDA 实现目标构成了威胁。尼日利亚团结支持基金（NSSF）与 NPHCDA 合作，在 3 个月内加速尼日利亚各地的 COVID-19 疫苗接种。
在尼日利亚的 6 个地理区域中，根据绩效、政治意愿和外部资源的缺乏，选择了 6 个州，即：阿达马瓦、江户、伊莫、 Katsina、纳萨拉瓦和奥贡州。实施了双管齐下的方法：向州以下一级提供无限制的资金，并在国家一级提供技术支持。
6 个州中的 5 个州获得了用于提高疫苗接种覆盖率的无限制资金。它们还获得了充足的疫苗供应。共有 12000 名卫生保健工作者接受了安全免疫接种实践的培训，通过宗教和社区领袖在 133 个地方政府区（LGAs）的多个社区进行了宣传。6 个月后，5 个州的 COVID-19 疫苗接种率平均增加了 35%。国家一级每周进行一次指标跟踪审查，尼日利亚接种疫苗的总人口从合作伙伴关系开始时的 6186647 人增加到 11985336 人。
无限制的资金投入虽然存在风险，但可以对卫生保健产生重大影响。该干预措施是与利益攸关方共同设计的，领导层有投入、有问责机制，并提供无限制的资金。这些技术使 5 个州和全国的疫苗接种率都有所提高。这些因素应该在其他方案设计中进行探讨，如常规免疫。
